|
Rivant Sciences Ltd. (Roiv) DCF -Bewertung
GB | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Roivant Sciences Ltd. (ROIV) Bundle
Entdecken Sie das wahre Potenzial von Roivant Sciences Ltd. (ROIV) mit unserem erweiterten DCF -Taschenrechner! Passen Sie die wichtigsten Annahmen an, erkunden Sie verschiedene Szenarien und untersuchen Sie die Auswirkungen von Änderungen auf die Bewertung von Roivant - alles innerhalb einer umfassenden Excel -Vorlage.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 67.7 | 23.8 | 55.3 | 61.3 | 124.8 | 170.3 | 232.5 | 317.4 | 433.2 | 591.3 |
| Revenue Growth, % | 0 | -64.85 | 132.34 | 10.84 | 103.65 | 36.5 | 36.5 | 36.5 | 36.5 | 36.5 |
| EBITDA | -553.3 | -895.7 | -916.7 | -1,178.0 | 4,310.2 | -102.2 | -139.5 | -190.4 | -259.9 | -354.8 |
| EBITDA, % | -817.42 | -3764.4 | -1658.12 | -1922.34 | 3453.86 | -60 | -60 | -60 | -60 | -60 |
| Depreciation | -20.9 | 175.2 | 5.9 | 18.9 | 22.0 | 43.7 | 59.7 | 81.5 | 111.2 | 151.8 |
| Depreciation, % | -30.84 | 736.12 | 10.73 | 30.77 | 17.66 | 25.66 | 25.66 | 25.66 | 25.66 | 25.66 |
| EBIT | -532.4 | -1,070.9 | -922.6 | -1,196.9 | 4,288.2 | -102.2 | -139.5 | -190.4 | -259.9 | -354.8 |
| EBIT, % | -786.58 | -4500.52 | -1668.85 | -1953.11 | 3436.2 | -60 | -60 | -60 | -60 | -60 |
| Total Cash | 2,185.5 | 2,132.7 | 2,060.4 | 1,681.8 | 6,541.1 | 170.3 | 232.5 | 317.4 | 433.2 | 591.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 15.3 | 13.8 | 6.7 | 37.6 | 82.8 | 75.2 | 102.6 | 140.1 | 191.2 | 261.0 |
| Account Receivables, % | 22.57 | 58.13 | 12.18 | 61.43 | 66.36 | 44.13 | 44.13 | 44.13 | 44.13 | 44.13 |
| Inventories | .0 | .0 | .0 | 2.8 | 35.3 | 11.2 | 15.2 | 20.8 | 28.4 | 38.7 |
| Inventories, % | 0.000001477345 | 0 | 0 | 4.51 | 28.25 | 6.55 | 6.55 | 6.55 | 6.55 | 6.55 |
| Accounts Payable | 10.3 | 20.6 | 34.6 | 37.8 | 53.2 | 91.5 | 124.9 | 170.4 | 232.7 | 317.6 |
| Accounts Payable, % | 15.23 | 86.36 | 62.55 | 61.73 | 42.65 | 53.7 | 53.7 | 53.7 | 53.7 | 53.7 |
| Capital Expenditure | -4.9 | -5.8 | -17.4 | -12.7 | -1.4 | -29.0 | -39.5 | -54.0 | -73.7 | -100.5 |
| Capital Expenditure, % | -7.26 | -24.4 | -31.54 | -20.71 | -1.11 | -17 | -17 | -17 | -17 | -17 |
| Tax Rate, % | -2.25 | -2.25 | -2.25 | -2.25 | -2.25 | -2.25 | -2.25 | -2.25 | -2.25 | -2.25 |
| EBITAT | 1,139.4 | -964.5 | -844.2 | -986.0 | 4,384.5 | -74.4 | -101.5 | -138.6 | -189.2 | -258.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 1,108.6 | -783.4 | -834.6 | -1,010.2 | 4,342.9 | 10.3 | -79.5 | -108.6 | -148.2 | -202.3 |
| WACC, % | 9.42 | 9.75 | 9.76 | 9.73 | 9.79 | 9.69 | 9.69 | 9.69 | 9.69 | 9.69 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -368.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -206 | |||||||||
| Terminal Value | -2,683 | |||||||||
| Present Terminal Value | -1,690 | |||||||||
| Enterprise Value | -2,058 | |||||||||
| Net Debt | -6,036 | |||||||||
| Equity Value | 3,978 | |||||||||
| Diluted Shares Outstanding, MM | 831 | |||||||||
| Equity Value Per Share | 4.79 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real ROIV financials.
- Real-World Data: Access to historical data and forward-looking estimates (highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe how your inputs affect Roivant Sciences’ valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive Financial Data: Gain access to precise historical data and future forecasts specific to Roivant Sciences Ltd. (ROIV).
- Adjustable Forecast Variables: Modify highlighted inputs such as discount rates, growth projections, and profit margins.
- Real-Time Calculations: Automatic adjustments for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries for a clear visualization of your valuation outcomes.
- Suitable for All Skill Levels: An intuitive design tailored for investors, financial officers, and consultants alike.
How It Works
- 1. Access the Model: Download and open the Excel file featuring Roivant Sciences Ltd.'s preloaded data.
- 2. Adjust Key Inputs: Modify essential parameters such as revenue growth, discount rates, and research expenditures.
- 3. Analyze Results in Real-Time: The DCF model automatically computes intrinsic value and net present value (NPV).
- 4. Explore Different Scenarios: Evaluate various projections to assess a range of valuation possibilities.
- 5. Present with Assurance: Share professional valuation findings to inform your strategic decisions.
Why Choose This Calculator for Roivant Sciences Ltd. (ROIV)?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters effortlessly to suit your analysis needs.
- Real-Time Adjustments: Observe immediate changes in Roivant's valuation as you modify inputs.
- Preloaded Data: Comes with Roivant's actual financial information for swift evaluations.
- Relied Upon by Experts: Utilized by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Investors: Evaluate Roivant Sciences' valuation before making stock transactions.
- CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts.
- Startup Founders: Discover how biotech companies like Roivant Sciences are valued in the market.
- Consultants: Provide comprehensive valuation reports for your clients in the healthcare sector.
- Students and Educators: Utilize real-world examples to teach and learn valuation strategies.
What the Template Contains
- Pre-Filled Data: Includes Roivant Sciences Ltd.'s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Roivant Sciences Ltd.'s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.